Autosomal dominant optic atrophy and cataract "plus" phenotype including axonal neuropathy.
Journal
Neurology. Genetics
ISSN: 2376-7839
Titre abrégé: Neurol Genet
Pays: United States
ID NLM: 101671068
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
16
11
2018
accepted:
01
02
2019
entrez:
24
5
2019
pubmed:
24
5
2019
medline:
24
5
2019
Statut:
epublish
Résumé
To characterize the phenotype in individuals with Two probands with multiple affected relatives and one sporadic case were referred for evaluation of a PN. Their phenotype was determined by clinical ± neurophysiological assessment. Neuropathologic examination of sural nerve and skeletal muscle, and ultrastructural analysis of mitochondria in fibroblasts were performed in one case. Exome sequencing was performed in the probands. The main clinical features in one family (n = 7 affected individuals) and one sporadic case were early-onset cataracts (n = 7), symptoms of gastrointestinal dysmotility (n = 8), and possible/confirmed PN (n = 7). Impaired vision was an early-onset feature in another family (n = 4 affected individuals), in which 3 members had symptoms of gastrointestinal dysmotility and 2 developed PN and cataracts. The less common features among all individuals included symptoms/signs of autonomic dysfunction (n = 3), hearing loss (n = 3), and recurrent pancreatitis (n = 1). In 5 individuals, the neuropathy was axonal and clinically asymptomatic (n = 1), sensory-predominant (n = 2), or motor and sensory (n = 2). In one patient, nerve biopsy revealed a loss of large and small myelinated fibers. In fibroblasts, mitochondria were frequently enlarged with slightly fragmented cristae. The exome sequencing identified A syndromic form of ADOAC (ADOAC+), in which axonal neuropathy may be a major feature, is described.
Identifiants
pubmed: 31119193
doi: 10.1212/NXG.0000000000000322
pii: NG2018009654
pmc: PMC6501639
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e322Subventions
Organisme : Medical Research Council
ID : MR/K000608/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S005021/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S01165X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601943
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S002065/1
Pays : United Kingdom
Références
Am J Hum Genet. 2001 Dec;69(6):1218-24
pubmed: 11668429
Mol Genet Metab. 2002 Jul;76(3):201-6
pubmed: 12126933
J Biol Chem. 2003 Mar 7;278(10):7743-6
pubmed: 12509422
J Biol Chem. 2003 Oct 17;278(42):41566-71
pubmed: 12865426
J Med Genet. 2004 Sep;41(9):e110
pubmed: 15342707
J Inherit Metab Dis. 2005;28(4):525-32
pubmed: 15902555
Mitochondrion. 2004 Sep;4(5-6):601-7
pubmed: 16120417
J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S419-23
pubmed: 18985435
Mol Genet Metab. 2010 Jun;100(2):149-54
pubmed: 20350831
Cell Mol Life Sci. 2010 Aug;67(16):2839-50
pubmed: 20372962
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Development. 2010 Aug 1;137(15):2587-96
pubmed: 20627962
Brain. 2011 Apr;134(Pt 4):e169; author reply e170
pubmed: 21112924
Invest Ophthalmol Vis Sci. 2011 Jun 21;52(7):4369-80
pubmed: 21613372
BMJ Open. 2012 Jan 05;2:e000411
pubmed: 22223843
Eur Neurol. 2012;68(2):108-10
pubmed: 22797356
PLoS One. 2013 May 03;8(5):e63495
pubmed: 23658835
JAMA Neurol. 2013 Jun;70(6):783-7
pubmed: 23700088
J Med Genet. 2013 Dec;50(12):848-58
pubmed: 24136862
Mol Genet Metab Rep. 2014 Jan 1;1:114-123
pubmed: 24749080
Neurology. 1989 Apr;39(4):595-7
pubmed: 2494568
Brain. 2014 Oct;137(Pt 10):e301
pubmed: 25012220
Brain. 2015 Jan;138(Pt 1):e321
pubmed: 25146916
Neurogenetics. 2015 Jan;16(1):69-75
pubmed: 25159689
J Neurol. 2014 Dec;261(12):2275-82
pubmed: 25201222
Neurobiol Dis. 2016 Jun;90:20-6
pubmed: 26311407
Cold Spring Harb Mol Case Stud. 2017 Jan;3(1):a001156
pubmed: 28050599
J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):846-863
pubmed: 28794150
Dev Med Child Neurol. 1994 Feb;36(2):167-72
pubmed: 7510656